PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 50 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $95,000 | +37.7% | 37,976 | +14.4% | 0.00% | – |
Q3 2020 | $69,000 | -34.9% | 33,210 | 0.0% | 0.00% | – |
Q2 2020 | $106,000 | +41.3% | 33,210 | +0.4% | 0.00% | – |
Q1 2020 | $75,000 | -33.0% | 33,069 | +7.2% | 0.00% | – |
Q4 2019 | $112,000 | -3.4% | 30,841 | -4.2% | 0.00% | – |
Q3 2019 | $116,000 | -23.7% | 32,178 | -0.5% | 0.00% | – |
Q2 2019 | $152,000 | +14.3% | 32,340 | -18.3% | 0.00% | – |
Q1 2019 | $133,000 | +40.0% | 39,584 | +11.7% | 0.00% | – |
Q4 2018 | $95,000 | -53.9% | 35,435 | -3.6% | 0.00% | – |
Q3 2018 | $206,000 | -3.7% | 36,746 | -12.7% | 0.00% | – |
Q2 2018 | $214,000 | +1.4% | 42,084 | +36.5% | 0.00% | – |
Q1 2018 | $211,000 | -4.5% | 30,837 | +5.2% | 0.00% | – |
Q4 2017 | $221,000 | +24.9% | 29,300 | -4.7% | 0.00% | – |
Q3 2017 | $177,000 | +9.9% | 30,730 | -3.3% | 0.00% | – |
Q2 2017 | $161,000 | +2200.0% | 31,785 | +1106.3% | 0.00% | – |
Q1 2017 | $7,000 | +75.0% | 2,635 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -20.0% | 2,635 | 0.0% | 0.00% | – |
Q3 2016 | $5,000 | +25.0% | 2,635 | 0.0% | 0.00% | – |
Q2 2016 | $4,000 | -20.0% | 2,635 | 0.0% | 0.00% | – |
Q1 2016 | $5,000 | – | 2,635 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |